ARX vs IDXX · rev $912.9M vs P/E 40, rev $2.36B
Accelerant Holdings (ARX) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Accelerant Holdings (ARX) is a insurance brokers company listed on NYSE.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported ARX revenue for 2025-12-31 was $912.9M. Net income was -$1.35B. Revenue was up 51.5% from 2024-12-31 to 2025-12-31. ARX currently screens at market cap $2.84B.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ARX currently screens at market cap $2.84B. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ARX and IDXX stock pages for the full models.
Not investment advice.